Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IgANSTAZA: Steroids + Azathioprine vs Steroids in IgA Nephropathy
NCT00755859Phase 4Completed
- Sponsor
- Ospedale Alessandro Manzoni
- Start
- May 1998
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, open-label trial of azathioprine in IgA nephropathy (IgAN) (2 arms), sponsored by Ospedale Alessandro Manzoni. Primary endpoint: Progression of renal disease up to 5 years. Started May 1998; status: completed.
02
Drugs
azathioprine
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00755859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755859.